GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pak Fah Yeow International 239.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

2.42

—

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Pak Fah Yeow International

Its shares trade on HKEX under the ticker 239.HK. It has been listed since 18 December 1991. In the fiscal year to 31 December 2024, it reported revenue of HK$236.8m and net income of HK$78.6m. At that date it held total assets of HK$843.4m and shareholders' equity of HK$731.9m.

Pak Fah Yeow International Ltd. is an investment holding company, which engages in the manufacture and sale of healthcare products under the brand name of Hoe Hin. The company employs 99 full-time employees The firm operates through three segments. The Healthcare segment is engaged in the manufacture and sales of healthcare products under the brand names of Hoe Hin products. The Property Investment segment is engaged in the investment in commercial, office, industrial and residential properties. The Treasury Investment segment is engaged in the equity and debt securities, mutual funds and dual currency investments businesses.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
18 Dec 1991
Employees
99

Leadership

Pay as last reported

  • Wee Sean GanExecutive Chairman of the Board, Chief Executive Officer, since 1991HK$7.5m
  • Mr. Hung Kei TsangChief Financial Officer, since 2009
  • Mr. Cheng Hooi GanBusiness Development Manager - HHPFY, Executive Director
  • Fock Wai GanExecutive Director, since 2008HK$5.0m
  • Ho Kwong TangHead of Sales and Marketing - Hoe Hin Pak Fah Yeow Manufactory, Limited
  • Lai Ching YauChief Operating Officer & Executive Director - Hoe Hin Pak Fah Yeow Manufactory Limited
  • Mr. Tai On LoCompany Secretary, since 2009
  • Ms. Fook Yin GanNon-Executive Director
  • Mr. Chi Chung ChanNon-Executive Independent Director
  • Mr. Renato Dell'ortoNon-Executive Independent Director
  • Mr. Man Chiu LeungIndependent Non-Executive Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Pak Fah Yeow International Ltd manufactures healthcare products under the Hoe Hin brand name.
  • The company operates through three distinct business segments including healthcare and property investment.
  • The firm employs 99 full-time employees to support its diverse operational activities.

Weaknesses

  • The company has a small workforce of only 99 full-time employees.
  • Reliance on the Hoe Hin brand limits product diversification within the healthcare segment.
  • The investment holding structure may complicate direct operational control over subsidiaries.

Opportunities

  • Expanding the Property Investment segment into new commercial and residential markets offers growth.
  • Investing in equity and debt securities can enhance returns for the Treasury segment.
  • Leveraging the established Hoe Hin brand can increase market share in healthcare.

Threats

  • Fluctuations in the property market could negatively impact the Property Investment segment.
  • Volatility in equity and debt securities poses risks to the Treasury Investment segment.
  • Changes in healthcare regulations may affect the manufacturing and sales of Hoe Hin products.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.